Ongoing Care in CKD Management and Results of EMPA Kidney Trial

The SGLT2i class of medications are increasingly used by physicians in Canada due to their multiple positive effects – long term survival, morbidity, and mortality rates of patients with complex medical conditions. Nevertheless, there remain unanswered questions. The results from the EMPA-KIDNEY trials will provide further insight on the effect of these drugs, and how the SGLT2is can be integrated into Canadian care moving forward. This educational lesson aims to incorporate the latest trial data findings and present these to the Canadian nephrology and endocrinology audience for quick dissemination.

Learning Objectives:

  • Review the evolving reno-protective role of the SGLT2is (Medical Expert, Scholar)
  • Analyze the results of the EMPA-KIDNEY trial and discuss how they align with previous CKD trials, exploring their implications for clinical practice (Medical Expert, Scholar)
  • Identify what gaps remain and how emerging data will influence how specialists manage CKD, particularly in patients with T2D (Communicator, Leader)

This activity is an Accredited Group Learning (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by The Canadian Society of Nephrology. You may claim a maximum of 1.5 hours (credits are automatically calculated in MAINPORT).

Agenda:

30 minutes

Arrival & Dinner Service

5 minutes

Welcome & Introductions

15 minutes

The evolution of SGLT2is

5 minutes

SGLT2is Mechanisms of Action: Current Understanding and Evolving Theories

20 minutes

Overview of EMPA-KIDNEY Results

25 minutes

Putting it All Together: What We Know Now and What Remains Undiscovered

30 minutes

Q&A : How Do EMPA-KIDNEY Results Change Nephrology Care Considerations

5 minutes

Closing Remarks and Evaluations

Live Events

(click to open event details)
November 15th, 2022 - Toronto
Delta Hotels by Marriott Toronto (Parkdale Room)
75 Lower Simcoe St
Toronto, ON
M5J 3A6
Arrival time & Dinner Service: 6:30pm Eastern Time
Presentation: 7:00pm-8:45pm

Faculty Presenters:

  • (Moderator) Dr. Jordan Weinstein MD, FRCPC (Ontario)
  • Dr. Alice Cheng MD, FRCPC (Ontario)
  • Dr. David Cherney MD, CM, PhD, FRCPC (Ontario)
  • Dr. Matthew Weir MD (Maryland, USA)

Register

November 16th, 2022 - Toronto
Spencer's At The Waterfront Restaurant (The Observatory Room)
1340 Lakeshore Rd
Burlington, ON
L7S 1B1
Arrival time & Dinner Service: 6:30pm Eastern Time
Presentation: 7:00pm-8:45pm

Faculty Presenters:

  • (Moderator and Speaker) Dr. Alice Cheng MD, FRCPC (Ontario)
  • Dr. David Cherney MD, CM, PhD, FRCPC (Ontario)
  • Dr. Matthew Weir MD (Maryland, USA)
Register
November 21st, 2022 - Calgary
The Inn on Officers Garden (The Event Hall)
150 Dieppe Drive Southwest
Calgary, AB
T3E 7L4
Arrival time & Dinner Service: 5:30pm MDT
Presentation: 6:00pm-7:45pm

Faculty Presenters:

  • (Moderator and Speaker) Dr. Sara Stafford MDCM, FRCPC (British Columbia)
  • Dr. Louis-Philippe Girard MD, MBT, FRCPC (Alberta)
  • Dr. Matthew Weir MD (Maryland, USA)
Register
November 22nd, 2022 - Vancouver
Seasons in the Park Restaurant (Summit Room)
W 33rd Ave
Vancouver, BC
V5Y 2M4
Arrival time & Dinner Service: 6:30pm Pacific Time
Presentation: 7:00pm-8:45pm

Faculty Presenters:

  • (Moderator and Speaker) Dr. Adeera Levin MD, FRCPC, FCAHS, OC (British Columbia)
  • Dr. Sara Stafford MDCM, FRCPC (British Columbia)
  • Dr. Matthew Weir MD (Maryland, USA)
Register
December 6th, 2022 - Montreal
W Montréal (The Gallery)
901 Rue du Square-Victoria
Montréal, QC
H2Z 1R1
Arrival time & Dinner Service: 6:30pm Eastern Time
Presentation: 7:00pm-8:45pm

This event will be held primarily in French, with simultaneous interpretation services and devices for attendees who require it. (French to English and English to French available)

Faculty Presenters:

  • (Moderator and Speaker) Dr. Normand Proulx MD, FRCPC (Québec)
  • Dr. David Cherney MD, CM, PhD, FRCPC (Ontario)
  • Dr. Stavroula Christopoulos MD, FRCPC (Québec)
Register

Virtual Events

(click to open event details)
November 21st, 2022
Zoom weblink to be emailed to registrants a few days before the session
6:00pm-7:45pm Mountain Time

 

Faculty Presenters:
  • (Moderator and Speaker) Dr. Sara Stafford MDCM, FRCPC (British Columbia)
  • Dr. Louis-Philippe Girard MD, MBT, FRCPC (Alberta)
  • Dr. Matthew Weir MD (Maryland, USA)

Register

December 6th, 2022

Zoom weblink to be emailed to registrants a few days before the session

7:00pm-8:45pm Eastern Time

This event will be held primarily in French, with phone-in simultaneous interpretation services for attendees who require it. (French to English and English to French available)

Faculty Presenters:

  • (Moderator and Speaker) Dr. Normand Proulx MD, FRCPC (Québec)
  • Dr. David Cherney MD, CM, PhD, FRCPC (Ontario)
  • Dr. Stavroula Christopoulos MD, FRCPC (Québec)

Register

Program Faculty

Planning Committee MemberDisclosures
JORDAN WEINSTEIN MD, FRCPC
CPD Network Representative (Physician Organization)
Associate Professor of Medicine
University of Toronto
Nephrologist, St. Michael’s Hospital
Director, UKidney.com
Toronto, ON
Dr. Weinstein received research funding, honoraria, as well as served on advisory boards and as a speaker, for CPD Network Association, BI-Lilly, Alexion, Merck, Amgen, Janssen, Otsuka, AstraZeneca, and Bayer.
ALICE Y.Y CHENG MD, FRCPC
Endocrinologist
Trillium Health Partners and Unity Health Toronto
Associate Professor, Department of Medicine
University of Toronto
Toronto, Ontario
Any direct financial payments including receipt of honoraria: Abbott, Amgen, Astra Zeneca, Bausch, Bayer, Boehringer Ingelheim, Dexcom, Eli Lilly, GSK, HLS Therapeutics, Insulet, Janssen, Medtronic, Merck, Novo Nordisk, Pfizer, Sanofi, Takeda, Antibody, EOCI, Six Degrees, Liv, CPD Network, Canadian Collaborative Research Network, Master Clinical Alliance, Canadian Medical & Surgical Knowledge Translation Research Group, Sea Courses, Alliance of Best Practices in Health Education, Partners in Progressive Medical Education, Agence Unik, MD Briefcase, LMC Physician Inc., Meducomm, Humber Hospital, Timed Right, The ACADEMY More
ADEERA LEVIN MD, FRCPC, FCAHS, OC
Head, Division of Nephrology
Professor of Medicine
University of British Columbia
Executive Director BC Renal
Medical Lead Integration Clinical and Academic Network PHC
Vancouver, BC
Membership on advisory boards or speakers’ bureaus: Boeingher Ingleheim, Astra Zeneca, Janssen
Funded grants or clinical trials: Boeingher Ingleheim, Astra Zeneca, Janssen, GSK, BI, AZ, GSK, Janssen, Chinook
Steering committee and chair of various DSMB: BI, AZ, GSK, Janssen, Chinook NIH, CIHR
NORMAND PROULX MD, FRCPC
Nephrologist
CISSS de l'Outaouais, Pavillon de Hull
Gatineau, QC
Part Time Lecturer, McGill University
Gatineau, QC
Membership on advisory boards or speakers’ bureaus: Janssen, Otsuka, AstraZeneca, Bayer, GSK CPD Network, Novo Nordisk

THIS PROGRAM HAS RECEIVED AN EDUCATIONAL GRANT OR IN-KIND SUPPORT FROM Boehringer-Ingelheim and Eli-Lilly

cpdisup